BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37941063)

  • 1. LncRNA MAFG-AS1 is involved in human cancer progression.
    Li P; Ma X; Gu X
    Eur J Med Res; 2023 Nov; 28(1):497. PubMed ID: 37941063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MAFG-AS1 Promotes Lung Adenocarcinoma Cell Migration and Invasion by Targeting miR-3196 and Regulating SOX12 Expression.
    Wu Q; Jiang J
    Mol Biotechnol; 2022 Sep; 64(9):970-983. PubMed ID: 35275356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis.
    Dabbaghi KG; Mashatan N; Faraz O; Bashkandi AH; Shomoossi N; Tabnak P
    Pathol Res Pract; 2023 Mar; 243():154348. PubMed ID: 36736142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenic roles of MAFG-AS1 in human cancers.
    Ahmadi M; Morshedzadeh F; Ghaderian SMH; Mousavi P; Habibipour L; Peymani M; Abbaszadegan MR; Ghafouri-Fard S
    Clin Transl Oncol; 2024 Jan; 26(1):52-68. PubMed ID: 37351806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
    Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
    Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1.
    Bai Y; Ren C; Wang B; Xue J; Li F; Liu J; Yang L
    Cancer Gene Ther; 2022 Mar; 29(3-4):277-291. PubMed ID: 34035482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis.
    Sui Y; Lin G; Zheng Y; Huang W
    Eur J Pharmacol; 2019 Sep; 859():172465. PubMed ID: 31211984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
    Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM
    Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15.
    Li H; Zhang GY; Pan CH; Zhang XY; Su XY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2838-2846. PubMed ID: 31002134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MAFG-AS1 Upregulates Polo-Like Kinase-1 by Sponging miR-505 to Promote Gastric Adenocarcinoma Cell Proliferation.
    Fu Y; Wen J; Li X; Gong M; Guo Z; Wang G
    Crit Rev Eukaryot Gene Expr; 2021; 31(5):27-32. PubMed ID: 34591387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor ETV1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial-mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize ETV1 expression.
    Weng H; Feng W; Li F; Huang D; Lin L; Wang Z
    Growth Factors; 2023 Aug; 41(3):152-164. PubMed ID: 37428861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers.
    Huang Z; Zhang M; Li J; Lou C
    Biomed Pharmacother; 2023 Jul; 163():114756. PubMed ID: 37105079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
    Li C; Wu R; Xing Y
    Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.
    Cui S; Yang X; Zhang L; Zhao Y; Yan W
    Biochem Biophys Res Commun; 2018 Nov; 506(1):251-258. PubMed ID: 30348529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.
    Feng J; Wen T; Li Z; Feng L; Zhou L; Yang Z; Xu L; Shi S; Hou K; Shen J; Han X; Teng Y
    Aging (Albany NY); 2020 Oct; 12(20):20658-20683. PubMed ID: 33098638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA.
    Zhang F; Li Y; Gan L; Tong X; Qi D; Wang Q; Ye X
    FASEB J; 2021 May; 35(5):e21529. PubMed ID: 33813778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MAFG-AS1 deregulated in breast cancer affects autophagy and progression of breast cancer by interacting with miR-3612 and FKBP4 invitro.
    Gao Z; Zheng G; Gong X; Hu H; Shao L; Pang Y; Wang Y; Qi A
    Biochem Biophys Res Commun; 2022 Aug; 616():95-103. PubMed ID: 35653827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MAFG-AS1-induced acute myeloid leukemia development via modulating miR-147b/HOXA9.
    Yao Q; Zhang L; Liu Z; Yu L; Wang Y; Liu J; Wang Y
    Environ Sci Pollut Res Int; 2023 Feb; 30(7):19250-19258. PubMed ID: 36229729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
    Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MAFG-AS1 affects the tumorigenesis of breast cancer cells via the miR-574-5p/SOD2 axis.
    Dai J; Zhang S; Sun H; Wu Y; Yan M
    Biochem Biophys Res Commun; 2021 Jun; 560():119-125. PubMed ID: 33989902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.